rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-3-6
|
pubmed:abstractText |
Adverse effects from narcotics complicate pain management in children. Ketorolac, a potent nonsteroidal antiinflammatory agent can be used as an adjuvant analgesic, yet concerns of bleeding and nephrotoxicity have limited routine use. The authors hypothesized that postoperative use of ketorolac in healthy pediatric surgical patients would limit narcotic requirements without increasing morbidity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-3468
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
76-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11150441-Analgesics, Opioid,
pubmed-meshheading:11150441-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:11150441-Case-Control Studies,
pubmed-meshheading:11150441-Child,
pubmed-meshheading:11150441-Drug Therapy, Combination,
pubmed-meshheading:11150441-Humans,
pubmed-meshheading:11150441-Ketorolac,
pubmed-meshheading:11150441-Morphine,
pubmed-meshheading:11150441-Pain, Postoperative,
pubmed-meshheading:11150441-Prospective Studies
|
pubmed:year |
2001
|
pubmed:articleTitle |
Ketorolac reduces postoperative narcotic requirements.
|
pubmed:affiliation |
Department of Surgery, Upstate Medical University, Syracuse, NY, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|